Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Original Article

R.J. Landovitz, D. Donnell, M.E. Clement, B. Hanscom, L. Cottle, L. Coelho, R. Cabello, S. Chariyalertsak, E.F. Dunne, I. Frank, J.A. Gallardo-Cartagena, A.H. Gaur, P. Gonzales, H.V. Tran, J.C. Hinojosa, E.G. Kallas, C.F. Kelley, M.H. Losso, J.V. Madruga, K. Middelkoop, N. Phanuphak, B. Santos, O. Sued, J.V. Huamaní, E.T. Overton, S. Swaminathan, C.d. Rio, R.M. Gulick, P. Richardson, P. Sullivan, E. Piwowar-Manning, M. Marzinke, C. Hendrix, M. Li, Z. Wang, J. Marrazzo, E. Daar, A. Asmelash, T.T. Brown, P. Anderson, S.H. Eshleman, M. Bryan, C. Blanchette, J. Lucas, C. Psaros, S. Safren, J. Sugarman, H. Scott, J.J. Eron, S.D. Fields, N.D. Sista, K. Gomez-Feliciano, A. Jennings, R.M. Kofron, T.H. Holtz, K. Shin, J.F. Rooney, K.Y. Smith, W. Spreen, D. Margolis, A. Rinehart, A. Adeyeye, M.S. Cohen, M. McCauley, and B. Grinsztejn

N Engl J Med 2021;385:595-608

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
08/11/2021
Course expires: 
08/12/2023

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Course closed

This course closed on Saturday, August 12, 2023 - 11:59pm.